rxstat › Shortages › Misoprostol Mifepristone

Misoprostol Mifepristone (Mifegymiso, Femyso) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Aug 18, 2026

Some Misoprostol Mifepristone products are in shortage in Canada (1 of 2 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 28, 2026.

A combination of medicines used together for medical abortion.

Products affected
1 / 2
In shortage since
Jul 27, 2026
Est. full return
Aug 28, 2026
Reports on file
10
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
FEMYSO
200MCG 200MG · TABLET KIT · LUPIN PHARMA CANADA LIMITED
DIN 02560569 · since Jul 27, 2026, est. end Aug 28, 2026 · Disruption of the manufacture of the drug.
Resolved
MIFEGYMISO
200MCG 200MG · TABLET KIT · LINEPHARMA INTERNATIONAL LIMITED
DIN 02444038 · ended Jun 9, 2025 · Delay in shipping of the drug.
Resolved
MIFEGYMISO
200MCG 200MG · TABLET KIT · LINEPHARMA INTERNATIONAL LIMITED
DIN 02444038 · ended Mar 8, 2023 · Delivery delays, manufacturing constraints, and lack of availability of active pharmaceutical ingredient (API).
Resolved
MIFEGYMISO
200MCG 200MG · TABLET KIT · LINEPHARMA INTERNATIONAL LIMITED
DIN 02444038 · ended Dec 20, 2022 · Delay in shipping of the drug.
Resolved
MIFEGYMISO
200MCG 200MG · KIT TABLET · LINEPHARMA INTERNATIONAL LIMITED
DIN 02444038 · ended Mar 27, 2020 · Delay in shipping of the drug.
Resolved
MIFEGYMISO
200MCG 200MG · KIT TABLET · LINEPHARMA INTERNATIONAL LIMITED
DIN 02444038 · ended Apr 8, 2019 · The DIN number printed on the carton is not correct
Resolved
MIFEGYMISO
200MCG 200MG · KIT TABLET · LINEPHARMA INTERNATIONAL LIMITED
DIN 02444038 · ended Apr 2, 2018 · Demand increase for the drug.
Resolved
MIFEGYMISO
200MCG 200MG · KIT TABLET · LINEPHARMA INTERNATIONAL LIMITED
DIN 02444038 · ended Jan 9, 2018 · Demand increase for the drug.
Resolved
MIFEGYMISO
200MCG 200MG · KIT TABLET · LINEPHARMA INTERNATIONAL LIMITED
DIN 02444038 · ended Oct 13, 2017 · Delay in shipping of the drug.
Resolved
MIFEGYMISO
200MCG 200MG · KIT TABLET · LINEPHARMA INTERNATIONAL LIMITED
DIN 02444038 · ended Oct 13, 2017 · Demand increase for the drug.

What's happening

Misoprostol Mifepristone is currently affected by an active shortage report filed with Health Canada by LUPIN PHARMA CANADA LIMITED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Misoprostol Mifepristone is classified under “OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM” (ATC G03XB).

Recent changes

Common questions

What is Misoprostol Mifepristone used for?

A combination of medicines used together for medical abortion.

When will Misoprostol Mifepristone be back in stock in Canada?

The latest manufacturer estimate is Aug 28, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Misoprostol Mifepristone in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (other sex horm. & modulators of the genital system)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Danazol (Cyclomen) No current shortage Raloxifene (Evista) Partial shortage 1 of 6 reported products affected · est. return Aug 21, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.